Novel modified adenosine 5′-triphosphate analogues pharmacologically characterized in human embryonic kidney 293 cells highly expressing rat brain P2Y1 receptor: Biotinylated analogue potentially suitable for specific P2Y1 receptor isolation

Biochemical Pharmacology

Volumn 61, Issue 10, 2001, Pages 1259-1269

  Zündorf, Gregor ^a   Schäfer, Rainer ^a   Vöhringer, Christian ^a   Halbfinger, Efrat ^b   Fischer, Bilha ^b   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Adenine nucleotides; Biotin; P2Y1 receptor ligands; Purinergic receptor; Receptor expression

Indexed keywords

2 [(6 BIOTINYLAMIDO)HEXYLTHIO]ADENOSINE TRIPHOSPHATE; 2 BUTYLAMINOADENOSINE PHOSPHATE; 2 BUTYLAMINOADENOSINE TRIPHOSPHATE; 2 BUTYLOXYADENOSINE PHOSPHATE; 2 BUTYLOXYADENOSINE TRIPHOSPHATE; 2 BUTYLTHIOADENOSINE DIPHOSPHATE; 2 BUTYLTHIOADENOSINE PHOSPHATE; 2 BUTYLTHIOADENOSINE TRIPHOSPHATE; 2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM ION; GREEN FLUORESCENT PROTEIN; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; HUMAN; HUMAN CELL; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; BIOTINYLATION; BRAIN; CALCIUM; CELLS, CULTURED; CHROMATOGRAPHY, AFFINITY; HUMANS; KIDNEY; RATS; RECEPTORS, PURINERGIC P2; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOTIDES;

EID: 0035873969     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00593-7     Document Type: Article

References (39)

1. The past, present and future of purine nucleotides as signalling molecules
2. Receptors for purines and pyrimidines
3. 2+ response evoked by ATP and other nucleotides in mammalian brain astrocytes
4. 2+ signalling in hippocampal astrocytes
5. Cloning of a human purinergic P2Y coupled to phospholipase C and adenylyl cyclase
6. Potent agonist action of 2-thioether derivatives of adenine nucleotides at adenylyl cyclase-linked P2Y purinoceptors
7. Adenosine and its nucleotides stimulate proliferation of chick astrocytes and human astrocytoma cells
8. Effects of ATP analogues and basic fibroblast growth factor on astroglial cell differentiation in primary cultures of rat striatum
9. Purinergic signalling: Pathophysiological roles
10. Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms
11. Current status of purinergic signalling in the nervous system
12. 1 purinergic receptor in the human brain: Striking neuronal localisation
13. Identification of potent, selective P2Y purinoceptor agonists: Structure-activity relationships for 2-thioether derivatives of adenosine 5′-triphosphate
14. 1 receptor. 1. A synthetic, biochemical, and NMR approach
15. 1 receptor. 2. A computational approach
16. 1 receptor tagged with green-fluorescent protein shows high-affinity ligand recognition of adenosine diphosphates and triphosphates and selectivity identical to that of the wild-type receptor
17. 1-purinoceptor
18. 1 receptor
19. Cloning of rat and mouse P2Y purinoceptors
20. Novel inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Chemical synthesis, biochemical and pharmacological characterizations
21. 2+ indicators with greatly improved fluorescence properties
22. The characterization and classification of receptors
23. Two novel families of ectonucleotidases: Molecular structures, catalytic properties and a search for function
24. 4 receptor
25. Cellular release of and response to ATP as key determinants of the set-point of signal transduction pathways
26. The classification of seven transmembrane receptors in recombinant expression systems
27. Molecular cloning and expression of an avian G protein-coupled P2Y receptor
28. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates
29. 2-thioether 5′-O-(thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y receptors
30. Identification of potent P2Y-purinoceptor agonists that are derivatives of adenosine 5′-monophosphate
31. Modelling the P2Y purinoceptor using rhodopsin as template
32. 1 receptor: Molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites
33. P2T purinoceptor antagonists. A QSAR study of some 2-substituted ATP analogues
34. 2+ channel in neurons, with both adenosine triphosphates and diphosphates as potent agonists
35. Agonist-specific receptor conformations
36. Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry
37. Expression cloning of an ATP receptor from mouse neuroblastoma cells
38. Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor
39. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors